Table 4.

Correlation analysis between presence of FH autoantibodies and clinical manifestations. Table indicates % of FH autoantibody–positive or –negative patients in the 2 cohorts (Serbian and Italian) and disease classifications (PAPS and SAPS) depending on the presence of the indicated manifestations. Disorders are displayed in collective terms and include the following: obstetric disorder including fetal losses; coagulation disorder including arterial or venous thrombosis and cerebral, pulmonary, or renal thrombosis; hematological disorder including hemolytic anemia, leukopenia, lymphopenia, or thrombocytopenia; heart disorder including infarction, unstable angina, vegetations, cardiomyopathy, and valve dysfunctions; neurological disorder including migraine, dementia, and epilepsy; pulmonary disorder including pulmonary hypertension, intraalveolar hemorrhage, and pulmonary microthrombosis; renal disorder including glomerular capillary thrombosis and renal vein thrombosis; cutaneous disorder including skin ulcerations, superficial necrosis, and digital gangrene.